Juvenile treatment with a novel mGluR2 agonist/mGluR3 antagonist compound, LY395756, reverses learning deficits and cognitive flexibility impairments in adults in a neurodevelopmental model of schizophrenia

Autor: Li, Meng-Lin a, b, c, Gulchina, Yelena b, Monaco, Sarah A. b, Xing, Bo b, Ferguson, Brielle R. b, Li, Yan-Chun b, Li, Feng d, ⁎, Hu, Xi-Quan a, ⁎, Gao, Wen-Jun b, ⁎
Zdroj: In Neurobiology of Learning and Memory April 2017 140:52-61
Databáze: ScienceDirect